...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Antigen delivery to CD11c+CD8- dendritic cells induces protective immune responses against experimental melanoma in mice in vivo
【24h】

Antigen delivery to CD11c+CD8- dendritic cells induces protective immune responses against experimental melanoma in mice in vivo

机译:抗原递送至CD11C + CD8-树突状细胞诱导对小鼠在体内小鼠的实验黑素瘤的保护性免疫应答

获取原文
获取原文并翻译 | 示例
           

摘要

Dendritic cells (DCs) are central modulators of immune responses and, therefore, interesting target cells for the induction of antitumor immune responses. Ag delivery to select DC subpopulations via targeting Abs to DC inhibitory receptor 2 (DCIR2, clone 33D1) or to DEC205 was shown to direct Ags specifically to CD11c+CD8- or CD11c+CD8 + DCs, respectively, in vivo. In contrast to the increasing knowledge about the induction of immune responses by efficiently cross-presenting CD11c+CD8+ DCs, little is known about the functional role of Ag-presenting CD11c+CD8+ DCs with regard to the initiation of protective immune responses. In this study, we demonstrate that Ag targeting to the CD11c+CD8- DC subpopulation in the presence of stimulating anti-CD40 Ab and TLR3 ligand polyinosinic-polycytidylic acid induces protective responses against rapidly growing tumor cells in naive animals under preventive and therapeutic treatment regimens in vivo. Of note, this immunization protocol induced a mixed Th1/Th2-driven immune response, irrespective of which DC subpopulation initially presented the Ag. Our results provide important information about the role of CD11c+CD8- DCs, which have been considered to be less efficient at cross-presenting Ags, in the induction of protective antitumor immune responses
机译:树突状细胞(DC)是免疫应答的中央调节剂,因此,用于诱导抗肿瘤免疫应答的有趣靶细胞。 Ag递送通过靶向ABS选择DC亚族蛋白酶至DC抑制受体2(DCIR2,克隆33d1)或DEC205分别在体内分别专门针对CD11C + CD8-或CD11C + CD8 + DC直接Ag。与关于通过有效交叉呈递CD11C + CD8 + DC的关于免疫应答诱导的越来越多的知识相反,关于AG呈递CD11C + CD8 + DC的功能作用对保护性免疫反应的起始时几乎是知之甚少。在该研究中,我们证明了在刺激抗CD40AB和TLR3配体的存在下靶向CD11C + CD8-DC群体的AG诱导预防性和治疗治疗方案下幼稚动物中快速生长肿瘤细胞的保护性反应体内。值得注意的是,这种免疫方案诱导了混合的Th1 / Th2驱动的免疫应答,而不管哪个DC亚贫化最初呈现Ag。我们的结果提供了有关CD11C + CD8-DCS的作用的重要信息,这些信息被认为在交叉呈递AGS诱导保护抗肿瘤免疫反应中的交叉呈递效率降低

著录项

  • 来源
  • 作者单位

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Institute for Medical Microbiology Immunology and Hygiene Technical University of Munich (TUM);

    Department of Geriatric and Environmental Dermatology Nagoya City University Graduate School of;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

    Proteomics Resource Center Rockefeller University New York 10065 United States;

    Laboratory of Molecular Immunology Rockefeller University New York 10065 United States;

    Department of Biology Friedrich-Alexander University Erlangen-Nürnberg 91058 Erlangen Germany;

    Department of Dermatology Laboratory of Dendritic Cell Biology University Hospital Erlangen;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 免疫遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号